Bayforest Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.6K Sell
725
-471
-39% -$19.8K 0.04% 652
2026
Q1
$38.5K Sell
1,196
-1,335
-53% -$49.4K 0.04% 627
2025
Q4
$107K Sell
2,531
-12,494
-83% -$504K 0.08% 451
2025
Q3
$516K Buy
+15,025
New +$431K 0.25% 130

Other funds holding VCYT

Bayforest Capital's VCYT Position: Q2 2026 in Review

Bayforest Capital reduced its Veracyte (VCYT) stake by 39% in Q2 2026, selling an estimated $19.8K and leaving 725 shares worth $42.6K. The position accounts for 0.04% of the portfolio, ranked #652.

Bayforest Capital first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. The position peaked at $516K in Q3 2025. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bayforest Capital held 725 shares of Veracyte worth $42.6K as of Q2 2026.
  • Bayforest Capital sold 471 Veracyte shares in Q2 2026, an estimated $19.8K.
  • Veracyte made up 0.04% of Bayforest Capital's portfolio in Q2 2026, its #652 holding.
  • Bayforest Capital first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • Bayforest Capital's Veracyte position peaked at $516K in Q3 2025.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.